Concepedia

Shruti V. Bendre

SV

3

Publications

38

Citations

3

H-Index

2022

Active since

Affiliations

University of Illinois Urbana-Champaign(Current)

University of Illinois Chicago

Shruti V. Bendre is an author at University of Illinois Urbana-Champaign specializing in tumor biology, oncology, and breast cancer.

ORCID

Top concepts

Publications per year

2022–2025

3

Publications

3

The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple- negative breast cancer

Adam T. Nelczyk, Liqian Ma, Anasuya Das Gupta et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2022 · 13 citations · Full text

, , +8

Cholesterol-targeting Wnt–β-catenin signaling inhibitors for colorectal cancer

Ashutosh Sharma, Julian Zalejski, Shruti V. Bendre et al. · Nature Chemical Biology · 2025 · 13 citations · Full text

Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells

Hashni Epa Vidana Gamage, Samuel T Albright, Amanda Smith et al. · Cancer Letters · 2024 · 12 citations · Full text

Rows per page

1–3 of 3